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The paper from Pyörä lä 's own group (Taponen et al., 2003) suffers from fundamental errors. Staphylococcal β-lactamase-negative pathogens were treated with systemic administration of 20 mg of procaine penicillin/ kg, and the β-lactamase producers were treated with 7 mg of amoxicillin/clavulanic acid/kg (clavulanic acid has no antibacterial effect). The procaine penicillin dose was 3 times higher than the amoxicillin dose for no obvious reason as was the co-administered intramammary dose (500 + 300 mg vs. 200 mg). Furthermore, the dose, dosing interval, and the susceptibility breakpoints for clavulanic acid in mastitis treatment have not been determined. To determine the β-lactamase production effect, both groups should have been treated with the same antibiotic (β-lactamase resistant). To establish the difference in efficacy of the two treatments, the cows should have been assigned to the study randomly, disregarding β-lactamase production. Therefore, the assigned groups in the study were under no circumstances comparable. Subsequently, these results cannot be used to support Pyörä lä 's criticism.
